By Maitane Sardon Dermapharm on Wednesday confirmed its outlook for the full year after posting a rise in first-half revenue. The German manufacturer of.
By Maitane Sardon Shares in Huber+Suhner dropped in early trading Tuesday after the Swiss manufacturer of fiber optic cable said it expects a decrease in.
By Maitane Sardon Valneva said Monday that the U.S. Food and Drug Administration has delayed the target date for completing the regulatory review of the.
By Maitane Sardon Shares in Valneva plunged in early trading Monday after the French biotech company said the U.S. Food and Drug Administration has delayed.